How I do it - selective amygdalohippocampectomy via subtemporal approach.

Area of Science:

• Neurosurgery
• Epileptology
• Neurology

Background:

• Pharmacoresistant mesial temporal lobe epilepsy (MTLE) secondary to hippocampal sclerosis is best managed surgically.
• Surgical options include standard temporal lobectomy and selective amygdalohippocampectomy.
• Selective amygdalohippocampectomy can be approached via transcortical, transsylvian, or subtemporal routes.

Purpose of the Study:

• To describe the technique of selective amygdalohippocampectomy using the subtemporal approach.
• To highlight the safety and efficacy of this surgical method.

Main Methods:

• Detailed preoperative evaluation for epilepsy surgery.
• Performance of selective amygdalohippocampectomy via the subtemporal surgical corridor.
• Emphasis on precise anatomical knowledge of the mesial temporal lobe.

Main Results:

• Selective amygdalohippocampectomy through the subtemporal approach is a feasible surgical procedure.
• The subtemporal approach allows for safe access to the mesial temporal structures.

Conclusions:

• Surgery is a superior treatment for pharmacoresistant MTLE with hippocampal sclerosis.
• Selective amygdalohippocampectomy via the subtemporal approach is a safe and effective surgical option.
• Thorough understanding of mesial temporal lobe anatomy is crucial for successful execution of this procedure.